Hypertension
Conditions
Interventions
AI Management Group:Patients receive 3 consecutive days of AI-facilitated interactive education covering: Medication adherence, Therapeutic lifestyle interventions (diet, exercise), Secondary hyperte
Routine Management Group:Standard hypertension care per physician’s clinical judgment, without AI support.
Sponsors
Department of Cardiology, Huashan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18–65 years, regardless of gender. 2. Newly diagnosed hypertensive patients: initial clinic blood pressure: 140–160/90–100 mmHg, and deemed by investigators to require oral pharmacological treatment (based on the 2025 Chinese Hypertension Guidelines or equivalent standards). 3. Previously diagnosed patients: currently on monotherapy (single antihypertensive agent), hypertension duration =1 year, and follow-up clinic blood pressure: 140–160/90–100 mmHg.
Exclusion criteria
Exclusion criteria: 1.History of atrial fibrillation, myocardial infarction, chronic heart failure, coronary heart disease, stroke, or specific types of cardiomyopathies. 2.Comorbidities involving significant organ damage or chronic wasting diseases (e.g., malignancies). 3.Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, or brain tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BP Control Rate: Defined as 24-hour ambulatory BP <130/80 mmHg. Measured at baseline and study end (day 60). ;Shared Decision-Making (SDM) Quality: Assessed using the Option12 Scale.; | — |
Secondary
| Measure | Time frame |
|---|---|
| BP Variability: Calculated from 24-hour ambulatory BP.;Medication Adherence: Evaluated via MMAS-8 scale.;Health-Promoting Behaviors: Measured using the HPLP-II R Scale.; | — |
Countries
China
Contacts
Public ContactLiwenBao
Department of Cardiology, Huashan Hospital
Outcome results
None listed